Trial intelligence / Profile preview

Nexsphere-F GAE vs Steroid Injection for Knee Osteoarthritis

NCT06872567Recruiting

Start
Oct 2025
Primary completion
Jun 2026
Countries
1
01

Overview

Randomised, open-label trial in knee osteoarthritis (OA). Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index at 12 months and Serious Adverse Events at 12 months. Started Oct 2025; status: recruiting.

02

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06872567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06872567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call